Amylyx Pharmaceuticals, Inc. (AMLX) vs Liquidia Corporation (LQDA)

Amylyx Pharmaceuticals, Inc. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. Liquidia Corporation is the larger, with a market value of $6.4B against $3.8B — 1.7× the size. Amylyx Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Liquidia Corporation trades at 43.6×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against −77.1%. Liquidia Corporation has the higher net margin (30.7% vs 0.00%) and the higher return on invested capital (121.1% vs 0.00%). Across the 17 metrics below, Liquidia Corporation leads on 13 and Amylyx Pharmaceuticals, Inc. on 4.